CDLX CARDLYTICS INC

Ownership history in FEDERATED HERMES, INC.  ·  11 quarters on record

This page tracks every 13F SEC filing in which FEDERATED HERMES, INC. reported a position in CARDLYTICS INC (CDLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2018 Q1)
Avg. % of fund
0.0%
First filed
2018 Q1
Last filed
2025 Q3
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,045 -5,731 -73.7% 0.00% $5K $2.43
2025 Q2 ADDED 7,776 +3,154 +68.2% 0.00% $13K $1.64
2025 Q1 REDUCED 4,622 -124,232 -96.4% 0.00% $8K $1.82
2023 Q1 ADDED 128,854 +27,101 +26.6% 0.00% $437K $3.39
2022 Q4 REDUCED 101,753 -32,238 -24.1% 0.00% $588K $5.78
2022 Q3 ADDED 133,991 +133,066 +14385.5% 0.00% $1.3M $9.40
2022 Q2 REDUCED 925 -19,074 -95.4% 0.00% $21K $22.31
2020 Q4 ADDED 19,999 +19,990 +222111.1% 0.01% $2.9M $142.77
2019 Q4 REDUCED 9 -93 -91.2% 0.00% $1K $62.86
2019 Q3 REDUCED 102 -399,898 -100.0% 0.00% $3K $33.52
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CDLX price (monthly, adj. close)
← Back to FEDERATED HERMES, INC. Holdings